Global and China Isothermal Nucleic Acid Amplification Technology/INAAT Dynamic Monitoring and Future Investment Report 2023
- Report Code : ARS2753564
- Published On: Jul, 2023
- Category : Healthcare & Pharma
- Pages : 126
-
The report aims at estimating the market size and future growth potential of Isothermal Nucleic Acid Amplification Technology/INAAT market across different segments such as type, application and geography. The base year considered for the study is 2022, and the market size is forecast from 2023 to 2029.
The global Isothermal Nucleic Acid Amplification Technology/INAAT market size in 2022 is 537320.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 13.10% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Isothermal Nucleic Acid Amplification Technology/INAAT market include Siemens (Germany), Hologic, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), and BD (U.S.). The share of the top 3 players in the Isothermal Nucleic Acid Amplification Technology/INAAT market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Isothermal Nucleic Acid Amplification Technology/INAAT market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Transcription-Mediated Amplification accounted for XX% of Isothermal Nucleic Acid Amplification Technology/INAAT market in 2022. Loop-Mediated Isothermal Amplification share of XX%.
Infectious Disease Diagnosis accounted for XX% of the Isothermal Nucleic Acid Amplification Technology/INAAT market in 2022. Hepatitis accounts for XX%.
The research methodology used to estimate and forecast the Isothermal Nucleic Acid Amplification Technology/INAAT market begins by capturing data on key market player revenues through secondary research. The bottom-up procedure has been employed to arrive at the overall market size, by considering the revenue of key players in the market. After arriving at the overall market size, the total market has been split into several segments and sub-segments, which has been verified through primary research by conducting extensive interviews with key people such as industry experts, executives. This data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for segments and sub-segments.
This report provides the integrated ecosystem of the Isothermal Nucleic Acid Amplification Technology/INAAT market which offers holistic view of current demand and vendor side market. The research study answers several significant questions, primarily which market segments to focus on in next two to five years to prioritize factors such as resource effort, and investment.
Key Target audience:
Isothermal Nucleic Acid Amplification Technology/INAAT Manufacturers and Suppliers
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Research Organizations
Academic Centers and Universities Associations and Industrial Bodies
Technology Investors
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Player list
Siemens (Germany)
Hologic, Inc. (U.S.)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
Abbott (U.S.)
BD (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
Thermo Fisher Scientific (U.S.)
Koninklijke Philips N.V. (Netherlands)
NeuroLogica Corp. (U.S.)
Shimadzu Medical (India) pvt. Ltd. (Japan)
General Electric (U.S.)
Quest Diagnostics Incorporated (U.S.)
Sysmex India Pvt. Ltd. (Japan)
Hitachi, Ltd. (Japan)
Canon Inc. (Japan)
FUJIFILM Holdings Corporation (U.K.)
Types list
Transcription-Mediated Amplification
Loop-Mediated Isothermal Amplification
Strand Displacement Amplification
Helicase-Dependent Amplification
Nucleic Acid Sequence-Based Amplification
Other Technologies
Application list
Infectious Disease Diagnosis
Hepatitis
Ct/Ng
HIV
Influenza
Other infectious diseases
Blood Screening
Other Applications
-
With tables and figures helping analyze worldwide Global and China Isothermal Nucleic Acid Amplification Technology INAAT Dynamic Monitoring and Future Investment market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Isothermal Nucleic Acid Amplification Technology/INAAT Market Introduction and Overview1.1 Isothermal Nucleic Acid Amplification Technology/INAAT Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
2 Isothermal Nucleic Acid Amplification Technology/INAAT Business Cost Analysis2.1 Proportion of Manufacturing Cost Structure
2.1.1 Labor Cost
2.1.2 Operating Expenses2.2 Isothermal Nucleic Acid Amplification Technology/INAAT Industrial Chain Analysis
3 Market Competition by Manufacturers3.1 Global Isothermal Nucleic Acid Amplification Technology/INAAT Revenue and Market Share by Manufacturer
3.2 Manufacturers Isothermal Nucleic Acid Amplification Technology/INAAT Production Sites, Area Served, Product Types
3.3 Isothermal Nucleic Acid Amplification Technology/INAAT Market Competitive Situation and Trends
3.3.1 Isothermal Nucleic Acid Amplification Technology/INAAT Market Concentration Rate
3.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
3.3.3 Mergers & Acquisitions, Expansion
4 Players Profiles4.1 Siemens (Germany)
4.1.1 Siemens (Germany) Company Profile
4.1.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.1.3 Siemens (Germany) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.1.4 Siemens (Germany) Business Overview4.2 Hologic, Inc. (U.S.)
4.2.1 Hologic, Inc. (U.S.) Company Profile
4.2.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.2.3 Hologic, Inc. (U.S.) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.2.4 Hologic, Inc. (U.S.) Business Overview4.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
4.3.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) Company Profile
4.3.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.3.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.3.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) Business Overview4.4 Abbott (U.S.)
4.4.1 Abbott (U.S.) Company Profile
4.4.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.4.3 Abbott (U.S.) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.4.4 Abbott (U.S.) Business Overview4.5 BD (U.S.)
4.5.1 BD (U.S.) Company Profile
4.5.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.5.3 BD (U.S.) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.5.4 BD (U.S.) Business Overview4.6 F. Hoffmann-La Roche Ltd (Switzerland)
4.6.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
4.6.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.6.3 F. Hoffmann-La Roche Ltd (Switzerland) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.6.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
4.7 Thermo Fisher Scientific (U.S.)
4.7.1 Thermo Fisher Scientific (U.S.) Company Profile
4.7.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.7.3 Thermo Fisher Scientific (U.S.) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.7.4 Thermo Fisher Scientific (U.S.) Business Overview
4.8 Koninklijke Philips N.V. (Netherlands)
4.8.1 Koninklijke Philips N.V. (Netherlands) Company Profile
4.8.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.8.3 Koninklijke Philips N.V. (Netherlands) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.8.4 Koninklijke Philips N.V. (Netherlands) Business Overview
4.9 NeuroLogica Corp. (U.S.)
4.9.1 NeuroLogica Corp. (U.S.) Company Profile
4.9.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.9.3 NeuroLogica Corp. (U.S.) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.9.4 NeuroLogica Corp. (U.S.) Business Overview4.10 Shimadzu Medical (India) pvt. Ltd. (Japan)
4.10.1 Shimadzu Medical (India) pvt. Ltd. (Japan) Company Profile
4.10.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.10.3 Shimadzu Medical (India) pvt. Ltd. (Japan) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.10.4 Shimadzu Medical (India) pvt. Ltd. (Japan) Business Overview
4.11 General Electric (U.S.)
4.11.1 General Electric (U.S.) Company Profile
4.11.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.11.3 General Electric (U.S.) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.11.4 General Electric (U.S.) Business Overview
4.12 Quest Diagnostics Incorporated (U.S.)
4.12.1 Quest Diagnostics Incorporated (U.S.) Company Profile
4.12.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.12.3 Quest Diagnostics Incorporated (U.S.) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.12.4 Quest Diagnostics Incorporated (U.S.) Business Overview
4.13 Sysmex India Pvt. Ltd. (Japan)
4.13.1 Sysmex India Pvt. Ltd. (Japan) Company Profile
4.13.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.13.3 Sysmex India Pvt. Ltd. (Japan) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.13.4 Sysmex India Pvt. Ltd. (Japan) Business Overview
4.14 Hitachi, Ltd. (Japan)
4.14.1 Hitachi, Ltd. (Japan) Company Profile
4.14.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.14.3 Hitachi, Ltd. (Japan) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.14.4 Hitachi, Ltd. (Japan) Business Overview
4.15 Canon Inc. (Japan)
4.15.1 Canon Inc. (Japan) Company Profile
4.15.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.15.3 Canon Inc. (Japan) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.15.4 Canon Inc. (Japan) Business Overview
4.16 FUJIFILM Holdings Corporation (U.K.)
4.16.1 FUJIFILM Holdings Corporation (U.K.) Company Profile
4.16.2 Isothermal Nucleic Acid Amplification Technology/INAAT Product Overview
4.16.3 FUJIFILM Holdings Corporation (U.K.) Isothermal Nucleic Acid Amplification Technology/INAAT Market Performance (2018-2023)
4.16.4 FUJIFILM Holdings Corporation (U.K.) Business Overview
5 Global Isothermal Nucleic Acid Amplification Technology/INAAT Historical and Forecast Market Analysis by Type5.1 Market Size Analysis by Types
5.2 Global Isothermal Nucleic Acid Amplification Technology/INAAT Revenue and Market Share by Type
5.3 Global Isothermal Nucleic Acid Amplification Technology/INAAT Revenue Market Forecast by Type (2023-2029)
6 Global Isothermal Nucleic Acid Amplification Technology/INAAT Historical and Forecast Market Analysis by Application6.1 Market Size Analysis by Application
6.2 Global Isothermal Nucleic Acid Amplification Technology/INAAT Revenue Market Share by Application (2018-2023)
6.3 Isothermal Nucleic Acid Amplification Technology/INAAT Revenue Market Forecast by Application (2023-2029)
7 Global Market Growth Trends Analysis7.1 Global Isothermal Nucleic Acid Amplification Technology/INAAT Market Size & Forecast (2018-2029)
7.2 Isothermal Nucleic Acid Amplification Technology/INAAT Growth Trends Analysis by Regions
7.2.1 Isothermal Nucleic Acid Amplification Technology/INAAT Market Size by Regions: 2018 VS 2023 VS 2029
7.2.2 Isothermal Nucleic Acid Amplification Technology/INAAT Historic Revenue Market Size by Regions (2018-2023)
7.2.3 Isothermal Nucleic Acid Amplification Technology/INAAT Forecasted Revenue Market Size by Regions (2023-2029)
7.2.4 North America Isothermal Nucleic Acid Amplification Technology/INAAT Market Size & Forecast (2018-2029)
7.2.5 EMEA Isothermal Nucleic Acid Amplification Technology/INAAT Market Size & Forecast (2018-2029)
7.2.6 China Isothermal Nucleic Acid Amplification Technology/INAAT Market Size & Forecast (2018-2029)
7.2.7 Asia-Pacific (Excluding China) Isothermal Nucleic Acid Amplification Technology/INAAT Market Size & Forecast (2018-2029)
7.2.8 Latin America Isothermal Nucleic Acid Amplification Technology/INAAT Market Size & Forecast (2018-2029)
8 North America8.1 North America Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Players
8.2 North America Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Types
8.3 North America Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Applications
8.4 North America Isothermal Nucleic Acid Amplification Technology/INAAT Market by Countries
8.4.1 North America Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Countries (2018-2029)8.5 North America SWOT Analysis
8.6 United States
8.7 Canada
9 China9.1 China Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Players
9.2 China Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Types
9.3 China Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Applications
9.4 China SWOT Analysis
9.5 China
10 Asia Pacific (Excluding China)10.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Players
10.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Types
10.3 Asia Pacific Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Applications
10.4 Asia Pacific Isothermal Nucleic Acid Amplification Technology/INAAT Market by Countries
10.4.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Countries (2018-2029)10.5 Asia Pacific SWOT Analysis
10.6 Japan
10.7 Korea
10.8 Southeast Asia
10.9 India10.10 Australia
11 EMEA11.1 EMEA Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Players
11.2 EMEA Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Types
11.3 EMEA Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Applications
11.4 EMEA Isothermal Nucleic Acid Amplification Technology/INAAT Market by Countries
11.4.1 EMEA Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Countries (2018-2029)11.5 EMEA SWOT Analysis
11.6 Europe
11.6.1 Europe Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Countries (2018-2029)
11.6.2 Germany
11.6.3 France
11.6.4 UK
11.6.5 Italy
11.6.6 Russia
11.6.7 Nordic
11.7 Middle East
11.8 Africa
12 Latin America12.1 Latin America Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Players
12.2 Latin America Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Types
12.3 Latin America Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Applications
12.4 Latin America Isothermal Nucleic Acid Amplification Technology/INAAT Market by Countries
12.4.1 Latin America Isothermal Nucleic Acid Amplification Technology/INAAT Revenue by Countries (2018-2029)12.5 Latin America SWOT Analysis
12.6 Brazil
12.7 Argentina
12.8 Mexico
13 Isothermal Nucleic Acid Amplification Technology/INAAT Industry Dynamic Analysis13.1 Isothermal Nucleic Acid Amplification Technology/INAAT Market Trends Analysis
13.2 Isothermal Nucleic Acid Amplification Technology/INAAT Market Drivers Analysis
13.3 Isothermal Nucleic Acid Amplification Technology/INAAT Market Challenges Analysis
13.4 Isothermal Nucleic Acid Amplification Technology/INAAT Market Restraints Analysis
14 Research Findings and Conclusion
-
The Global and China Isothermal Nucleic Acid Amplification Technology INAAT Dynamic Monitoring and Future Investment Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Global and China Isothermal Nucleic Acid Amplification Technology INAAT Dynamic Monitoring and Future Investment Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Depending upon the type of applications, the Global and China Isothermal Nucleic Acid Amplification Technology INAAT Dynamic Monitoring and Future Investment Market has been segmented into
The Global and China Isothermal Nucleic Acid Amplification Technology INAAT Dynamic Monitoring and Future Investment Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Global and China Isothermal Nucleic Acid Amplification Technology INAAT Dynamic Monitoring and Future Investment Market as well as its distribution among its players
The Global and China Isothermal Nucleic Acid Amplification Technology INAAT Dynamic Monitoring and Future Investment Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.
